Dr. Atish Narayanrao Bakane

Paediatric Hemato-Oncologist and BMT Expert
DNB Paediatrics , FIAP , FNB , MBBS , DCH
European Society of Blood and Marrrow Transplant (EBMT) Certified
Above 11 Years of Experience

Dr. Atish Narayanrao Bakane is one of the most prominent and dynamic Paediatric Hemato-Oncologist and BMT Expert India with international repute who has an experience of working with most experienced centres. Hematopoetic Stem cell Transplantation is considered as the most precise form of curative modalities for various benign and malignant disorders Currently he is working as Principal Consultant and Head of the Department Paediatric Hemato-Oncology, Bone marrow transplantation and Cellular therapy at NewEra hospital and research centre, Nagpur, Maharashtra.

Formerly he worked as Consultant PHO & BMTCT, Apollo Hospital, Delhi.

Dr Atish has a vast experience of working at leading hospitals of India including state of art cancer facility at Apollo Cancer centre, Chennai; King Edvard Medical college and hospital, Mumbai; Sir Gangaram Hospital, New Delhi and many others. He went to Spain to get further training in Hematopoietic Stem Cell Transplantation and successfully completed International Transplantation course under the aegis of European Blood and Marrow Transplantation.


  • Senior-Consultant - Senior Consultant Pediatric Hematologist Oncologist and BMT physician. Ray of Hope Centre of excellence in Pediatric Hematology Oncology and BMT and New Era Hospital.

  • Consultant - Dept of Pediatric hemato Oncology,Immunology and BMTCT,Indraprastha Apollo Hopsital,Delhi-From 1/4/2021 till date.

  • Associate Consultant - Dept of Pediatric Hemato Oncology,Immunology and BMTCT,Indraprastha Apollo Hopsital,Delhi-8th May 2019 To 31/3/2021

  • Associate Consultant - Dept of Pediatric Hemato Oncology amd BMT,Artemis Hospital, Gurgaon, Haryana-16th April 2018 to 7th May 2019.

  • FNB (Fellowship of National Board in Pediatric Hemato Oncology)recognised as super specialisation in India by Delhi Medical Council and National Medical Commision(previously MCI) - Sir Gangaram Hospital,New Delhi,India-6th April 2016 to 5th April 2018

  • Indian academy of Pediatrics (IAP) Fellowship in Pediatric Hemato Oncology-Sir Gangaram Hospital,New Delhi -6th April 2016 to 5th April 2018

  • Senior Resident - Department Of Pediatric Hemato Oncology and Stem cell transplant unit, Apollo Speciality Hospital,Chennai,TamilNadu,India-28th June 2015 to 28Feb 2016.


He has several years of experience and training in India at resident , registrar and consultant level. He also has experience in paediatric Haemato Oncology and BMT in different tertiary care hospitals in India, as registrar and fellow and was involved actively in evaluating and treating patients with primary immunodeficiency disorders, Leukemias, Lymphomas, solid tumours including Neuroblastoma, Rhabdomyosarcoma, Retinoblastoma, Ewing’s sarcoma, PNET, GCT, Brain tumours and other rare tumours. My training in both general paediatric and paediatric specialities include outpatients, in patients, day care, and on calls responsibilities. He also have research experience.

He has successfully completed European Blood and Marrow Transplantation ( EBMT) international transplant course from Barcelona, Spain in 2018.

He has been invited for fellowship in PHO and BMT by Great Ormand Street Hospital London, but could not go due to Covid 19 Pandemic.


  • Kharya G, Bakane A, Rauthan A.Pre-Transplant Myeloid and Immune Suppression, Reduced Toxicity Conditioning with Post-Transplant Cyclophosphamide: Initial Outcomes of Novel Approach for Matched Unrelated Donor Hematopoietic Stem Cell Transplant for Hemoglobinopathies. DOI: 10.1002/pbc.28909. Pediatric Blood & Cancer.

  • “Raj R, Aboobacker FN, Yadav SP, Uppuluri R, Bhat S, Choudhry D, Dua V, Kharya G, Rastogi N, Sachdev M, Khandelwal V, Swaminathan V, Bakane A, Ramakrishnan B and George B (2021) Multicenter Outcome of Hematopoietic Stem Cell Transplantation for Primary Immune Deficiency Disorders in India. Front. Immunol. 11:606930. doi: 10.3389/fimmu.2020.6069”

  • Bakane A, R Archana, M Anjan, Kharya G. Successful T cell depleted Haploidentical HSCT For a Novel NK-E 2 Mutation Causing Inherited Thrombocytopenia, Pedaitric Blood and Cancer.2020 DOI10.22541/au.160188494.47312822.

  • Kharya G, Bakane A, Agarwal S, Rauthan A. Pre-transplant myeloid and immune suppression, upfront plerixafor mobilization and post-transplant cyclophosphamide: novel strategy for haploidentical transplant in sickle cell disease. Bone Marrow Transplant. 2020;10.1038/s41409-020-01054-3. doi:10.1038/s41409-020-01054-3

Copyright © 2023 RJ Solutions. All rights reserved.     Design: RJ Solutions